Renu, A, Millan, M, San Roman, L, Blasco, J, Marti-Fabregas, J, Terceno, M, Amaro, S, Serena, J, Urra, X, Laredo, C, Barranco, R, Camps-Renom, P, Zarco, F, Oleaga, L, Cardona, P, Castano, C, Macho, J, Cuadrado-Godia, E, Vivas, E, Lopez-Rueda, A, Guimaraens, L, Ramos-Pachon, A, Roquer, J, Muchada, M, Tomasello, A, Davalos, A, Torres, F, Chamorro, A. Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke The CHOICE Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2022; 327(9)DOI:10.1001/jama.2022.1645. PMID:35143603. IF:120.700(Q1/1D).

Millán M, Ramos-Pachón A, Dorado L, Bustamante A, Hernández-Pérez M, Rodríguez-Esparragoza L, Gomis M, Remollo S, Castaño C, Werner M, Wenger D, Rubio S, Domínguez-Lizarbe M, Terceño M, Paipa AJ, Rodríguez-Vázquez A, Boned S, Camps-Renom P, Cánovas D, Giralt E, López-Cancio E, Dávalos A, Ros-Roig J, Pérez de la Ossa N. Predictors of Functional Outcome After Thrombectomy in Patients With Prestroke Disability in Clinical Practice. STROKE. 2022; 53(3)DOI:10.1161/STROKEAHA.121.034960. PMID:34702065. IF:8.300(Q1/1D).

Lindgren, AG, Braun, RG, Majersik, JJ, Clatworthy, P, Mainali, S, Derdeyn, CP, Maguire, J, Jern, C, Rosand, J, Cole, JW, Lee, JM, Khatri, P, Nyquist, P, Debette, S, Wei, LK, Rundek, T, Leifer, D, Thijs, V, Lemmens, R, Heitsch, L, Prasad, K, Conde, JJ, Dichgans, M, Rost, NS, Cramer, SC, Bernhardt, J, Worrall, BB, Fernandez-Cadenas, I. International stroke genetics consortium recommendations for studies of genetics of stroke outcome and recovery. International Journal of Stroke. 2022; 17(3)DOI:10.1177/17474930211007288. PMID:33739214. IF:6.700(Q1/2D).

Aapkes, SE, Bernts, LHP, van den Berg, AP, van den Berg, M, Blokzijl, H, Cantineau, AEP, van Gastel, MDA, de Haas, RJ, Kappert, P, Muller, RU, Nevens, F, Torra, R, Visser, A, Drenth, JPH, Gansevoort, RT. Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study. BMC GASTROENTEROLOGY. 2022; 22(1)DOI:10.1186/s12876-022-02142-y. PMID:35216547. IF:2.400(Q4/9D).

Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Birules, I, Barajas, A, Lorente-Rovira, E, Diaz-Cutraro, L, Verdaguer, M, Garcia-Mieres, H, Sevilla-Llewellyn-Jones, J, Gutierrez-Zotes, A, Grasa, E, Pousa, E, Huerta-Ramos, E, Pelaez, T, Barrigon, ML, Gonzalez-Higueras, F, Ruiz-Delgado, I, Cid, J, Moritz, S, Ochoa, S. Persons with first episode psychosis have distinct profiles of social cognition and metacognition (vol 9, 61, 2021). SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-021-00199-4. PMID:35210466. IF:5.400(Q2/3D).

Pinana, JL, Vazquez, L, Martino, R, de la Camara, R, Sureda, A, Rodriguez-Veiga, R, Garrido, A, Sierra, J, Ribera, JM, Torrent, A, Mateos, MV, de la Rubia, J, Tormo, M, Diez-Campelo, M, Garcia-Gutierrez, V, Alvarez-Larran, A, Sancho, JM, MartinGarcia-Sancho, A, Yanez, L, Simon, JAP, Barba, P, Abrisqueta, P, Alvarez-Twose, I, Bonanad, S, Lecumberri, R, Ruiz-Camps, I, Navarro, D, Hernandez-Rivas, JA, Cedillo, A, Garcia-Sanz, R, Bosch, F. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. LEUKEMIA & LYMPHOMA. 2022; 63(3)DOI:10.1080/10428194.2021.1992619. PMID:34668835. IF:2.600(Q3/7D).

Boenink, R, Astley, ME, Huijben, JA, Stel, VS, Kerschbaum, J, Ots-Rosenberg, M, Asberg, AA, Lopot, F, Golan, E, de la Nuez, PC, Camblor, MR, Trujillo-Aleman, S, San Millan, JCR, Mingo, PU, Diaz, JM, Bouzas-Caamano, ME, Artamendi, M, Madre, MA, de Pablos, CS, Roblero, MFS, Zurriaga, O, Stendahl, ME, Bell, S, Idrizi, A, Ioannou, K, Debska-Slizien, A, Galvao, AA, De Meester, JM, Resic, H, Hommel, K, Radunovic, D, Palsson, R, Lassalle, M, Finne, P, Bazaga, MD, Gjorgjievski, N, Seyahi, N, Bonthuis, M, Ortiz, A, Jager, KJ, Kramer, A. The ERA Registry Annual Report 2019: summary and age comparisons. Clinical Kidney Journal. 2022; 15(3)DOI:10.1093/ckj/sfab273. PMID:35211303. IF:4.600(Q1/2D).

Roca, N, Jatem, E, Abo, A, Santacana, M, Cruz, A, Madrid, A, Fraga, G, Martin, M, Gonzalez, J, Martinez, C, Balius, A, Segarra, A. CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome. Clinical Kidney Journal. 2022; 15(3)DOI:10.1093/ckj/sfab215. PMID:35211308. IF:4.600(Q1/2D).